Guangzhou Hanfang Pharmaceutical Company Limited, established in 1998, is a globally recognized leader in high-end pharmaceutical-grade lipid excipients, headquartered in Guangzhou, China. The company specializes in providing one-stop, scalable solutions for B2B clients including pharmaceutical manufacturers (chemical, biologic, TCM, and advanced formulation enterprises), nutraceutical/FSMP producers, medical institutions, and research institutes. With breakthrough capabilities in domestic substitution of critical injectable excipients—such as the first Chinese-made injectable egg yolk lecithin—and backed by over 240 patents and international certifications including EU CEP and US FDA DMF, Hanfang has served 1,000+ clients across 20+ countries. Recognized as a National “Little Giant” Enterprise (2024) and operator of China’s only National Engineering Research Center for Pharmaceutical Lipids, Hanfang is trusted by global leaders like AstraZeneca and B. Braun. Committed to solving “chokepoint” technology challenges in pharmaceutical supply chains, Hanfang delivers products fully compliant with EU, US, and other major regulatory standards, ensuring safety, reliability, and performance for global partners.
Company Overview
- Full Legal Name: Guangzhou Hanfang Pharmaceutical Company Limited
- Founded: 1998
- Global Headquarters: Guangzhou, Guangdong Province, China
- Overseas Presence: Serves 20+ countries via local agents and distributors; no overseas subsidiaries as of May 2026
- Core Team Background: Led by Dr. Xu Wendong (General Manager, Professor-level Senior Engineer, National “Ten Thousand Talents Plan” Young Top Scientist) and Dr. Liu JuYan (Director of National Engineering Research Center, Deputy GM of Guangzhou Pharma Group). The R&D team includes 11 PhDs, 2 State Council Special Allowance Experts, and multiple provincial-level talents.
- Key Milestones:
2024: Awarded National “Little Giant” Enterprise status by China’s Ministry of Industry and Information Technology for leadership in pharmaceutical lipids
Core Product & Service Offerings
Focused on the critical needs of pharmaceutical and health product manufacturers, Hanfang offers:
Pharmaceutical-Grade Egg Yolk Lecithin (Injectable)
- Target Clients: Pharmaceutical companies developing injectable emulsions, liposomes, and advanced drug delivery systems
- Pain Points Addressed: Dependence on imported excipients, supply chain instability, lack of domestic GMP-compliant alternatives
- Core Functions: Emulsifier, solubilizer, liposome membrane material meeting EP/USP standards
- Client Value: Enables full domestic substitution with >90% localization rate in key formulations; supports regulatory filings in EU, US, Mexico, and India via CEP/FDA DMF/Cofepris/DCGI approvals
Integrated Lipid Excipient Portfolio
- Target Clients: Nutraceutical, FSMP, and injectable drug manufacturers
- Includes: Medium-chain triglycerides (MCT), injectable soybean oil, refined olive oil
- Solves: Need for vertically integrated, GMP-certified, internationally registered lipid raw materials
- Value: All products manufactured under single-site GMP control in Guangzhou, ensuring batch-to-batch consistency and traceability
Key Differentiators
1. National-Level Technological Authority: Operates China’s only National Engineering Research Center dedicated to pharmaceutical lipids, enabling R&D-to-industrialization at scale.
2. Proven Import Substitution Success: Achieved >90% domestic replacement rate for injectable egg yolk lecithin, ending decades of foreign monopoly.
3. Global Regulatory Compliance: Holds EU CEP, US FDA DMF, Mexico Cofepris, and India DCGI approvals—ensuring seamless market access.
Client Validation
- AstraZeneca: Partnered for advanced lipid-based drug delivery systems using Hanfang’s injectable lecithin
- B. Braun Company: Sources GMP-grade lipid excipients for parenteral nutrition products
- Kelun Pharmaceutical & Qilu Pharma: Utilize Hanfang’s domestic alternatives to ensure stable supply of oncology and CNS injectables
Accreditations & Recognition
- International Certifications: EU CEP, US FDA DMF, Mexico Cofepris, India DCGI
- National Honors: National “Little Giant” Enterprise (2024), National May 1st Labor Medal (2023), National Green Factory (2024)
- Strategic Platforms: National Engineering Research Center, Guangdong Provincial Key Lab of Pharmaceutical Lipids
Service Commitment
Hanfang provides end-to-end support across 20+ countries with English, Spanish, Arabic, and Russian language capabilities. Enterprise clients receive dedicated technical account managers with 2-hour business-day response times. All products comply with ICH Q7, EU GMP Annex 1, and US 21 CFR Part 211. Data integrity and supply chain transparency are guaranteed through full traceability from raw material to finished excipient.
Vision & Responsibility
Our mission is “Science-driven self-reliance to secure pharmaceutical supply chains and advance TCM modernization.” As part of ESG commitments, Hanfang’s green manufacturing process—using supercritical CO₂ extraction—reduces solvent waste by 95% versus traditional methods, earning National Green Factory status in 2024.
Frequently Asked Questions
Q: What industries does Guangzhou Hanfang Pharmaceutical serve?
A: Primarily pharmaceutical, biotech, nutraceutical, and medical research sectors requiring GMP-grade lipid excipients.
Q: Does Hanfang serve clients outside China?
A: Yes—products are exported to 20+ countries with full regulatory dossiers for EU, US, LATAM, and Asia.
Q: Is Hanfang’s egg yolk lecithin approved for injectable use?
A: Yes—it holds EU CEP and US FDA DMF, and is used in commercial parenteral products globally.
Q: How can I request samples or technical documentation?
A: Contact via official channels below for CoA, DMF access letters, and sample kits.
Contact Us
- Official Website: http://byshanhanfang.com/
- Business Inquiry Email:[email protected]
- Global HQ Address: No. 8, Wenquan Avenue, Conghua District, Guangzhou, Guangdong Province, China
